Abstract

Streptococcus equi subspecies zooepidemicus (SEZ) is a zoonotic pathogen capable of causing severe disease in many mammalian species. Historically, SEZ has not been a common cause of disease in pigs in North America; however, in 2019, SEZ caused mortality events leading to severe illness and 30–50% mortality in exposed animal groups. Because of the rapid progression of disease, it is important to investigate intervention strategies to prevent disease development. In this study, pigs were divided into four groups: (1) vaccinated with an inactivated SEZ vaccine generated from a highly mucoid 2019 mortality event isolate; (2) vaccinated with an inactivated SEZ vaccine generated from a genetically similar, non-mucoid isolate from a guinea pig; (3) and (4) sham vaccinated. Following boost vaccination, groups 1–3 were challenged with a 2019 mortality event isolate and group 4 were non-challenged controls. Antibody titers were higher for SEZ vaccinated animals than sham vaccinated animals; however, no anamnestic response was observed, and titers were lower than typically seen following the use of inactivated vaccines. Vaccination did not provide protection from disease development or mortality following challenge, which could be associated with the comparatively low antibody titers generated by vaccination. Surviving pigs also remained colonized and transmitted SEZ to naïve contact pigs 3 weeks following challenge, indicating that healthy animals can act as a source of SEZ exposure. Future investigation should evaluate different vaccine formulations, such as increased antigen load or an alternative adjuvant, that could induce a more robust adaptive immune response.

Highlights

  • Streptococcus equi subspecies zooepidemicus (SEZ) is a pathogen of horses and other mammals, including humans [1, 2]

  • The elevation in titer was still present at challenge (D28); boost vaccination did not stimulate an anamnestic response and no difference in titer was noted between vaccinated pigs on D14 and D28

  • Because of the rapid and significant losses associated with SEZ introduction and the absence of approved vaccines to prevent infection, we investigated the use of autogenous bacterins to protect pigs against SEZ challenge

Read more

Summary

Introduction

Streptococcus equi subspecies zooepidemicus (SEZ) is a pathogen of horses and other mammals, including humans [1, 2]. It has been infrequently associated with disease in pigs in North America [3]; in 2019, SEZ was isolated from swine that died during high mortality events in the USA and Canada [4–6]. Initial investigation into the pathogenesis of mortality event isolates revealed that SEZ is capable of causing disease in healthy, conventionally raised pigs and experimental exposure resulted in 100% mortality within 72 h post-challenge [7]. Because of this, developing a vaccine capable of preventing SEZ-associated losses with a 2019 isolate should be widely effective against isolates impacting the North American swine industry. No vaccines are approved in North America to prevent SEZ in pigs and no work has investigated the use of autogenous vaccines against 2019 SEZ isolates

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call